Result: Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2022

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

Liver international. - 42, 11 (2022) , 2538-2547, ISSN: 1478-3231

*DOI*:

10.1111/liv.15405

*Result*: Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma